| Publications | PubMed=16107020
Mikhailova I.N., Lukashina M.I., Baryshnikov A.Y., Morozova L.F., Burova O.S., Palkina T.N., Kozlov A.M., Golubeva V.A., Cheremushkin E.A., Doroshenko M.B., Demidov L.V., Kiselev S.L., Larin S.S., Georgiev G.P.
Melanoma cell lines as the basis for antitumor vaccine preparation.
Vestn. Ross. Akad. Med. Nauk 2005:37-40(2005) CLPUB00681
Berezhnoy A.E., Zakeyeva I.R., Kibardin A.V., Chernysheva A.D., Moiseyenko V.M., Danilov A.O., Demidov L.V., Baryshnikov A.Y., Gnuchev N.V., Georgiev G.P., Larin S.S.
Analysis of HLA-E expression in human melanoma cells.
Ross. Bioterap. Zh. 5:66-71(2006) Patent=RU2287576
Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Berezhnoy A.E., Kozlov A.M., Larin S.S., Georgiev G.P., Vorozhtsov G.N., Gnuchev N.V.
Human melanoma cellular line mel Ibr used in preparing antitumor vaccine.
Patent number RU2287576, 20-Nov-2006 PubMed=18781128; DOI=10.1097/CMR.0b013e32830e391d
Mikhailova I.N., Kovalevsky D.A., Morozova L.F., Golubeva V.A., Cheremushkin E.A., Lukashina M.I., Voronina E.S., Burova O.S., Utyashev I.A., Kiselev S.L., Demidov L.V., Beabealashvilli R.S., Baryshnikov A.Y.
Cancer/testis genes expression in human melanoma cell lines.
Melanoma Res. 18:303-313(2008) PubMed=26388567; DOI=10.1007/s10517-015-3007-5
Suraeva N.M., Morozova L.F., Samoylov A.V., Burova O.S., Golubeva V.A., Baryshnikova M.A., Baryshnikov A.Y.
Changes in the morphological and immunological characteristics of Mel Ibr melanoma cells in response to chicken embryo extract.
Bull. Exp. Biol. Med. 159:520-523(2015) CLPUB00680
Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S., Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M., Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.
Human skin melanoma cell lines collection.
(In book chapter) Management of malignant melanoma; None X. (eds.); pp.6.1-6.6; SM Group; Dover; USA (2016) PubMed=28726209; DOI=10.1007/s10517-017-3778-y
Suraeva N.M., Morozova L.F., Ryabaya O.O., Khochenkova Y.A., Samoylov A.V., Burova O.S., Golubtsova N.V., Barmashov A.E., Baryshnikova M.A.
Characteristics of Mel Ibr melanoma line subclone after treatment with chicken embryo extract.
Bull. Exp. Biol. Med. 163:255-259(2017) PubMed=28881731; DOI=10.18632/oncotarget.17014; PMCID=PMC5581030
Emelyanova M., Ghukasyan L., Abramov I., Ryabaya O., Stepanova E.V., Kudryavtseva A., Sadritdinova A., Dzhumakova C., Belysheva T., Surzhikov S., Lyubchenko L., Zasedatelev A., Nasedkina T.
Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.
Oncotarget 8:52304-52320(2017) DOI=10.17650/1726-9784-2018-17-4-27-35
Mikhailova I.N., Treshalina H.M., Morozova L.F., Andronova N.V., Shubina I.Z., Lushnikova A.A.
Cell lines of human melanoma and their xenograft with BRAF or NRAS mutations a targets for targeted therapy.
Ross. Bioterap. Zh. 17:27-35(2018) |
|---|
